Publication

The rationale and study design of two phase II trials examining the effects of BI 685509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis

Reiberger, Thomas; Berzigotti, Annalisa; Trebicka, Jonel; Ertle, Judith; Gashaw, Isabella; Swallow, Ros; Tomisser, Andrea

London : BioMed Central (2023)
Journal Article

In
Trials24(1), Page(s)/Article-Nr.: 293

Institutions

  • IT Center [022000]